rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Elisabeth Sandoval Little

Director

Company insider

Files Form 4 as: Director, PROCEPT BioRobotics; Director, VYNE Therapeutics; Director, Satsuma Pharmaceuticals; Director, Intersect ENT; CCO & EVP, Corporate Strategy, Alder Biopharmaceuticals; Chief Commerical Officer, Kythera Biopharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
62
Buys
0
Sells
4
Bought
$0
Sold
$6.5M
Companies
6
Companies where not an officer
4
First trade
29 Jan 2015
Last trade
9 Jun 2026
Last filed
10 Jun 2026

Companies traded

Where they are an officer
Alder BiopharmaceuticalsOfficer · last 16 Feb 20180 buys · 0 sells
Kythera BiopharmaceuticalsOfficer · last 1 Oct 20150 buys · 4 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PRCT PROCEPT BioRoboticsDirector · Medical Devices · last 9 Jun 20260 buys · 0 sells
VYNE TherapeuticsDirector · Biotechnology · last 12 Dec 20250 buys · 0 sells
Satsuma PharmaceuticalsDirector · last 8 Jun 20230 buys · 0 sells
Intersect ENTDirector · last 13 May 20220 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 10 Jun 2026PRCT PROCEPT BioRoboticsMedical DevicesSEC FORM 4 Code A—3,315 at $0.00filing
9 Jun 2026filed 10 Jun 2026PRCT PROCEPT BioRoboticsoption or derivative · Medical DevicesSEC FORM 4 Code A—5,853 at $0.00filing
9 Jun 2026filed 10 Jun 2026PRCT PROCEPT BioRoboticsoption or derivative · Medical DevicesSEC FORM 4 Code A—5,853 at $0.00filing
9 Jun 2026filed 10 Jun 2026PRCT PROCEPT BioRoboticsMedical DevicesSEC FORM 4 Code A—3,315 at $0.00filing
12 Dec 2025filed 15 Dec 2025VYNE Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
10 Jun 2025filed 12 Jun 2025PRCT PROCEPT BioRoboticsoption or derivative · Medical DevicesSEC FORM 4 Code A—2,771 at $0.00filing
10 Jun 2025filed 12 Jun 2025PRCT PROCEPT BioRoboticsMedical DevicesSEC FORM 4 Code A—1,538 at $0.00filing
12 Dec 2024filed 13 Dec 2024VYNE Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
4 Jun 2024filed 6 Jun 2024PRCT PROCEPT BioRoboticsoption or derivative · Medical DevicesSEC FORM 4 Code A—2,526 at $0.00filing
4 Jun 2024filed 6 Jun 2024PRCT PROCEPT BioRoboticsMedical DevicesSEC FORM 4 Code A—1,376 at $0.00filing
1 Jan 2024filed 3 Jan 2024VYNE Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
13 Dec 2023filed 15 Dec 2023VYNE Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
15 Jun 2023filed 16 Jun 2023PRCT PROCEPT BioRoboticsoption or derivative · Medical DevicesSEC FORM 4 Code A—4,865 at $0.00filing
15 Jun 2023filed 16 Jun 2023PRCT PROCEPT BioRoboticsMedical DevicesSEC FORM 4 Code A—2,711 at $0.00filing
8 Jun 2023filed 8 Jun 2023Satsuma Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—10,000 at $0.00filing
8 Jun 2023filed 8 Jun 2023Satsuma Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—20,000 at $0.00filing
8 Jun 2023filed 8 Jun 2023Satsuma Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—30,000 at $0.00filing
8 Jun 2023filed 8 Jun 2023Satsuma Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—14,893 at $0.00filing
10 Aug 2022filed 12 Aug 2022VYNE Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,500 at $0.00filing
7 Jun 2022filed 9 Jun 2022PRCT PROCEPT BioRoboticsoption or derivative · Medical DevicesSEC FORM 4 Code A—4,205 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.